Carl Icahn is preparing a proxy fight at Illumina, arguing that the life science maker’s acquisition of Grail cost its shareholders roughly $50 billion.
You are here: Home / Carl Icahn reportedly prepares for a proxy fight at Illumina
Market News and Views
Carl Icahn is preparing a proxy fight at Illumina, arguing that the life science maker’s acquisition of Grail cost its shareholders roughly $50 billion.